These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36777097)

  • 1. Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma.
    Fang X; Zhang T; Chen Z
    Int J Gen Med; 2023; 16():481-497. PubMed ID: 36777097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4B, a potential prognostic biomarker revealed by large-scale public databases and clinical samples in uterine corpus endometrial carcinoma.
    Zhang M; Liu Y; Hou S; Wang Y; Wang C; Yin Y; Chen X
    Mol Omics; 2022 Jul; 18(6):506-519. PubMed ID: 35485290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis indicates SLC7A11 expression regulate the prognostic value of KEAP1-NFE2L2-CUL3 mutations in human uterine corpus endometrial carcinoma.
    Namani A; Veeraiyan D; Patra T
    Free Radic Biol Med; 2024 Sep; 222():223-228. PubMed ID: 38876457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FAT2 mutation is associated with better prognosis and responsiveness to immunotherapy in uterine corpus endometrial carcinoma.
    Wang Z; Xing L; Huang Y; Han P
    Cancer Med; 2023 Feb; 12(3):3797-3811. PubMed ID: 36812126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma.
    Wang G; Fu J; Liu M; Zheng Q
    PLoS One; 2024; 19(1):e0277872. PubMed ID: 38232115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNF183 Is a Prognostic Biomarker and Correlates With Tumor Purity, Immune Infiltrates in Uterine Corpus Endometrial Carcinoma.
    Geng R; Zheng Y; Zhao L; Huang X; Qiang R; Zhang R; Guo X; Li R
    Front Genet; 2020; 11():595733. PubMed ID: 33324448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma.
    He K; Li J; Huang X; Zhao W; Wang K; Wang T; Chen J; Wang Z; Yi J; Zhao S; Zhao L
    Front Oncol; 2023; 13():1090779. PubMed ID: 36776306
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
    Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL9 correlates with antitumor immunity and is predictive of a favorable prognosis in uterine corpus endometrial carcinoma.
    Xue S; Su XM; Ke LN; Huang YG
    Front Oncol; 2023; 13():1077780. PubMed ID: 36845675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammaglobin B may be a prognostic biomarker of uterine corpus endometrial cancer.
    Li J; Xu W; Zhu Y
    Oncol Lett; 2020 Nov; 20(5):255. PubMed ID: 32994818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma.
    Li D; Zhang J; Wu L; Yang X; Chen Z; Yuan J
    Cancer Manag Res; 2021; 13():7311-7323. PubMed ID: 34584457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of N-7 methylguanine-related mRNA prognostic model in uterine corpus endometrial carcinoma based on multi-omics data and immune-related analysis.
    Zhao J; Zou J; Jiao W; Lin L; Wang J; Lin Z
    Sci Rep; 2022 Nov; 12(1):18813. PubMed ID: 36335189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of Oxidative Stress-Related Genes Risk Model Predicts the Prognosis of Uterine Corpus Endometrial Cancer Patients.
    Liu Q; Yu M; Zhang T
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer.
    Lei P; Wang H; Yu L; Xu C; Sun H; Lyu Y; Li L; Zhang DL
    Int Immunopharmacol; 2022 Jul; 108():108743. PubMed ID: 35413679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma.
    Guo C; He Y; Chen L; Li Y; Wang Y; Bao Y; Zeng N; Jiang F; Zhou H; Zhang L
    Front Oncol; 2022; 12():1030246. PubMed ID: 36439473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
    Chen Y
    Front Genet; 2022; 13():912037. PubMed ID: 35937995
    [No Abstract]   [Full Text] [Related]  

  • 17. LAMP3 is a potent uterine corpus endometrial carcinoma prognostic biomarker associated with immune behavior.
    Fu B; Zhou M; Geng X; Jiang Y; Zeng H; Zhou X; Yu Z; Pan J; Zhu Y; Zheng H; Huang S; Gong Y; Huang D; Zhong Y
    Aging (Albany NY); 2024 Jan; 16(1):714-745. PubMed ID: 38217544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma.
    Jiang N; Li D; Han Y; Luo ZG; Liu LB
    Aging (Albany NY); 2024 Jun; 16(11):9784-9812. PubMed ID: 38848146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma.
    Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR
    Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma.
    Cai Y; Cui J; Wang Z; Wu H
    Transl Cancer Res; 2022 Jul; 11(7):1994-2012. PubMed ID: 35966302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.